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The findings of the recent independent review of the UK Liverpool Care Pathway 
(LCP)1, following substantial concerns raised by members of the public and health 
professionals found that the implementation of the LCP is often associated with poor 
care1. The Neuberger Report highlighted the complexity of various ethical, safety, 
clinical practice and negligence issues associated with pathway usage and how, 
despite technological advances, diagnosing dying continues to be challenging1. The 
UK Government’s decision to phase out the LCP as policy following these findings, 
has generated considerable debate both within and beyond the UK2. However, another 
key issue raised by the Neuberger’s report is the issue of the palliative care 
community’s perceived willingness to readily adopt new clinical practices in the 
absence of evidence. It is this translational issue that this editorial explores.  
 
In the thirty five years from 1970, the proportion of peer-reviewed publications in 
palliative care in relation to all publications more than doubled3. Arguably the quality 
has also improved, with one in every 122 controlled clinical trials ever published in 
the literature as a whole being in palliative and supportive care4. Much of the 
literature is distributed throughout a very large number of journals3, making the 
process of assembling and synthesising the data an ongoing challenge. These findings 
confirm the concerted effort that palliative care researchers are making into 
continuing to build a strong evidence base for clinical practice and for public policy.  
 
Despite these positive developments, the Neuberger report highlighted that nearly 10 
years after its widespread dissemination, prospective testing of the LCP had yet to be 
undertaken at a level of rigor sufficient to adequately support crucial national policy 
decisions1. Several before and after studies have been conducted, reporting positive 
effects of the LCP5-7. The common shortfalls of these studies variously included the 
lack of control arms, data collection that was not contemporaneous and sampling that 
lacked comparable groups8. Data from these studies can be seen as hypothesis 
generating, allowing more refined design for subsequent rigorous investigations, but 
should not be seen as definitive in and of themselves. Further, these data have been 
complemented with a number of non-experimental studies (i.e. reviews, letters, audits, 
case reports and qualitative studies) supporting the effectiveness of the LCP for 
improving outcomes8, 9. Study designs and articles of this type, while useful, should 
never be used to conclude effectiveness. Even when combined, this evidence should 
not have been seen as sufficient to change practice at a national level anywhere 
around the world.  
 
The widespread adoption of the LCP in many countries suggests that there was a 
willingness in the sector on this occasion to translate evidence into practice 
prematurely8-10, while conversely it remains challenging for other high level evidence 
from well conducted trials to be adopted efficiently11, 12. It is speculative, yet 
reasonable to assume that if high level evidence indicated that the LCP was truly 
effective and where had been quantified so they could be mitigated, the current status 
of LCP could have been different. 
 
The limitations to conducting palliative and end-of-life care research are well 
recognised, but these barriers should be viewed as challenges that require further 
efforts to address effectively, rather than used as the rationale for settling for a lower 
level of evidence upon which clinical practice and policy decisions are made. The 
research team led by Costantini should be congratulated for their research program 
investigating the effects of the LCP. This team sought to systematically develop 
through a rigorous program of research that operationalise the Medical Research 
Council (MRC) framework for evaluating complex interventions13-16. 
 
The concepts of evidence-based medicine are less than two decades old. As such, how 
do we as a global clinical community in palliative care support each other to develop 
the requisite critical appraisal skills? This requires a whole-of-sector approach in 
order to use the available evidence as effectively as possible. To achieve this, 
palliative care should only be taught by those who have the clinical expertise as well 
as the competency in evidence-based healthcare and critical appraisal skills. Palliative 
care professionals must continue, where data are lacking, to find ways to improve the 
evidence base by extending existing research to address current gaps in knowledge. 
This asks a great deal of a clinical community that has come late to developing the 
evidence that can underpin key decisions and implementing such knowledge 
systematically17. 
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